HtrA Serine Peptidase 4 (HTRA4) Peptide
-
- Target See all HTRA4 products
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LKMHYPDFPD VSSGVYVCKV VEGTAAQSSG LRDHDVIVNI NGKPITTTTD
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HTRA4 antibody,
Alternative Names: HTRA4 control peptide, HTRA4 antibody Blocking Peptide, Anti-HTRA4 Blocking Peptide, Htra Serine Peptidase 4 Blocking Peptide, FLJ90724 Blocking Peptide - Purification
- Immunoaffinity chromatography.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- HTRA4 (HtrA Serine Peptidase 4 (HTRA4))
- Synonyms
- B430206E18Rik Peptide, RGD1306242 Peptide, HtrA serine peptidase 4 Peptide, HTRA4 Peptide, Htra4 Peptide
- Background
- HTRA4 is a member of the HtrA family of proteases. The protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging.
- Molecular Weight
- 51 kDa
-